RecallGuide.ca
    Health productsUpdated Jan 3, 2026Teva CanadaOfficial source

    Teva 5-ASA tablet recall in Canada: Product quality issue

    Share:

    In plain language

    This recall involves Teva 5-ASA tablets (Mesalamine) sold in Canada. It's being recalled because the dissolution stability test is out of specification in affected lots, indicating a product quality issue. Consult your healthcare provider before stopping use and follow the steps in the official notice.

    What to do

    • Consult your healthcare provider prior to discontinuing use.
    • Verify if your product is affected by checking lot numbers.
    • Contact Teva Canada Limited if you have questions about the recall.
    • Report any health product related side effects to Health Canada.

    Get alerts for recalls like this

    Get email alerts when new recalls affect products in this category.

    Categories (optional)

    No spam. Unsubscribe anytime. We only email when there's a relevant recall.

    Affected products

    • Teva 5-ASA tablet (aka MESALAMINE)

      Lot: 100048018, 100037651, 100037650, 100053047

    Do I have this product?

    This recall only applies to specific products. Follow the steps below to check.

    1. 1

      Check the product name

      Make sure your product name matches one of the affected products listed above.

    2. 2

      Check the lot number

      Lot numbers identify specific production batches.

      Affected lots: 100048018, 100037651, 100037650, 100053047

    If your product matches one or more of the details above, it may be affected by this recall.

    If your product does not match these details, it is not affected by this recall.

    When in doubt, always check the official notice.

    Want alerts if similar products are recalled in Canada?

    Frequently Asked Questions

    Why was this product recalled?

    This recall involves Teva 5-ASA tablets (Mesalamine) sold in Canada. It's being recalled because the dissolution stability test is out of specification in affected lots, indicating a product quality issue. Consult your healthcare provider before stopping use and follow the steps in the official notice.

    What should consumers do?

    Consult your healthcare provider prior to discontinuing use. Verify if your product is affected by checking lot numbers. Contact Teva Canada Limited if you have questions about the recall. Report any health product related side effects to Health Canada.

    Where was the product sold?

    This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.

    Is there a health risk?

    A potential safety risk has been identified with this product. Stop using it immediately and follow the instructions in the official recall notice.

    When was this product recalled?

    This product was recalled on April 7, 2025.

    Is the Teva Canada brand affected by this recall?

    Yes, Teva Canada products are affected by this recall. This recall involves Teva 5-ASA tablets (Mesalamine) sold in Canada. It's being recalled because the dissolution stability test is out of specification in affected lots, indicating a product quality issue. Consult your healthcare provider before stopping use and follow the steps in the official notice.